Stock Markets
0
FMCG Penny Stock Sarveshwar Foods Skyrockets by 2400% Since March 2020
0

Sarveshwar Foods Limited, an Indian company, specializes in producing and selling basmati and non-basmati rice. They offer various types of rice, including ...

0
Stocks to Watch: Paytm, Eris Life, Biocon, Ashok Leyland, Vedanta, IIFL Finance
0

Eris Lifesciences, Biocon: Eris Lifesciences, a company specializing in branded formulations, is set to buy the domestic branded formulation business of ...

0
FedFina Stock, Trading Below IPO Price, Receives ‘Buy’ Ratings from 3 Brokerages with Potential Upside of up to 47%
0

FedFina, currently priced at ₹125, is down almost 11% from its IPO price. Despite a weak debut, brokerages rate it a 'buy,' citing its diverse product ...

0
Capital Small Finance Bank IPO Opens Today: Is it Worth Subscribing?
0

Ahead of its launch, Capital Small Finance Bank secured ₹57 crore from anchor investors, including Whiteoak Capital, Nippon Life India, Edelweiss Tokio Life ...

0
Nova Agritech’s Impressive Debut: Buy, Sell, or Hold Post Listing?
0

Nova Agritech witnessed a stellar debut on the stock exchanges today, opening at ₹55, a remarkable 34 percent premium over the issue price of ₹41 on the BSE. ...

0
Hindalco Stock Update:At its 52-week high today, is the metal stock a ‘buy’ at this moment?
0

Scheduled for commissioning by July 2025, the facility will initially manufacture 25,000 tonnes of aluminum foil, a crucial component in lithium-ion and ...

0
Stocks to Watch: Tata Tech, Gandhar Oil, Thomas Cook, JSW Infra, Bank of Baroda
0

In the trading spotlight for Thursday are these 10 stocks:Tata Technologies: This global engineering services company, a subsidiary of Tata Motors, is ...

0
Elara Securities Maintains ‘Sell’ Recommendation on RITES Despite 43% Stock Surge
0

Despite a significant 43% surge in RITES stock in the year-to-date 2023, Elara Securities has reiterated its 'sell' call on the company, setting a target ...

0
Axis Securities Identifies Aarti Drugs as ‘Top Pick of the Week,’ Cites 4 Key Factors
0

Axis Securities, in its latest analysis, designates Aarti Drugs as the 'Top Pick of the Week,' underlining four compelling reasons for a 'buy' recommendation ...

Share Price India News
Logo